G. Lazzari, “The Impact of KEYNOTE-522 Related Immune-Related Adverse Events on Concurrent Adjuvant Whole Breast Radiotherapy in the Real World: A Case Series: KEYNOTE-522 and adjuvant hypofractionated RT”, Arch Breast Cancer, vol. 12, no. 2, pp. 231–235, Apr. 2025.